Page last updated: 2024-08-17

trypan blue and Glaucoma, Neovascular

trypan blue has been researched along with Glaucoma, Neovascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chalam, KV; Rusovici, R; Sakhalkar, M	1

Other Studies

1 other study(ies) available for trypan blue and Glaucoma, Neovascular

Article	Year
Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells. Molecular vision, 2011, Volume: 17 Topics: Angiogenesis Inhibitors; Animals; Annexin A5; Anterior Chamber; Antibodies, Monoclonal, Humanized; Bevacizumab; Cattle; Cell Proliferation; Cell Survival; Cells, Cultured; Cornea; Dose-Response Relationship, Drug; Endothelial Cells; Glaucoma, Neovascular; Humans; Microscopy; Neovascularization, Pathologic; Trypan Blue; Vascular Endothelial Growth Factor A	2011

Article

Year

Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.

Molecular vision, 2011, Volume: 17

Topics: Angiogenesis Inhibitors; Animals; Annexin A5; Anterior Chamber; Antibodies, Monoclonal, Humanized; Bevacizumab; Cattle; Cell Proliferation; Cell Survival; Cells, Cultured; Cornea; Dose-Response Relationship, Drug; Endothelial Cells; Glaucoma, Neovascular; Humans; Microscopy; Neovascularization, Pathologic; Trypan Blue; Vascular Endothelial Growth Factor A

2011